| NCT ID | NCT05993221 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Providence VA Medical Center |
| Condition | Stroke |
| Study Type | OBSERVATIONAL |
| Enrollment | 75 participants |
| Start Date | 2023-09-05 |
| Primary Completion | 2027-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 75 participants in total. It began in 2023-09-05 with a primary completion date of 2027-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
TRACTs (DeconsTructing Post StRoke HemipAresis for PreCision NeurorehabiliTation) is a single timepoint study that aims to deconstruct post-stroke deficits of the upper extremity into distinct components and relate these components to brain anatomy and physiology.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of a unilateral ischemic stroke occurring \>6 months prior as documented in medical chart * Upper extremity motor impairment as measured by Fugl-Meyer Upper Extremity Assessment ≤60 * Ability to follow simple instructions in English Exclusion Criteria: * Greater than moderate difficulty using the arm and hand pre-dating the stroke as assessed by the questions adapted from the QuickDASH outcome measure score on any question \>= 3, which measures physical function and symptoms in people with difficulty using the arm and hand. * Visual or auditory disorders resulting in the inability to see or hear, respectively, the stimuli presented as part of research sessions * Inability to maintain a seated position for at least one hour * Standard MRI exclusion (e.g., significant claustrophobia or inability to tolerate loud noises, cardiac pacemaker (unless MRI-safe), implanted device (deep brain stimulation) or metal in the brain, cervical spinal cord, or upper thoracic spinal cord) * Standard (single-pulse) TMS exclusion which include (in addition to those listed for MRI) pregnancy/lactation/planning to become pregnant during the study, seizure disorder, and primary or secondary CNS tumors
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05993221 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05993221 currently recruiting?
Yes, NCT05993221 is actively recruiting participants. Contact the research team at jennifer.hebert@va.gov for enrollment information.
Where is the NCT05993221 trial being conducted?
This trial is being conducted at Providence, United States.
Who is sponsoring the NCT05993221 clinical trial?
NCT05993221 is sponsored by Providence VA Medical Center. The trial plans to enroll 75 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.